The transition from R&D to GMP does not need to represent a conflict between innovation and compliance. The most successful organisations recognise that quality systems support scientific progress. ...more
GMP
July 13, 2026•5 min read

GMP does not begin at a single identifiable moment. It begins as soon as controlled processes and regulated decision-making become necessary to ensure product quality and patient safety. ...more
GMP
June 29, 2026•6 min read

Evidence and data integrity expectations evolve progressively across GLP, GCP, and GMP environments, reflecting the increasing regulatory and patient impact of the data being generated. ...more
Quality Culture ,GMP
June 18, 2026•7 min read

Regulatory transparency in Good Manufacturing Practice (GMP) oversight is entering a period of structural change, driven by increasing expectations from regulators, industry stakeholders, and the broa... ...more
GMP
June 13, 2026•7 min read

The increasing emphasis on transparency in Good Manufacturing Practice (GMP) inspection outcomes represents a structural change in regulatory expectations across therapeutic goods manufacturing, biote... ...more
GMP
June 08, 2026•6 min read

The Therapeutic Goods Administration (TGA) has commenced a public consultation on a proposal to increase transparency regarding Good Manufacturing Practice (GMP) inspection outcomes for manufacturers ... ...more
GMP
June 08, 2026•5 min read
